Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: Three new cases and a review of the literature.

Antibodies against adenylate kinase 5 (AK5) have been described in patients with non-paraneoplastic limbic encephalitis, mainly in men around 70 years of age. Routine testing with specific cell-based assays is not yet available. Three patients with episodic anterograde memory problems and depression had extensive limbic lesions and developed severe atrophy, mainly of the medial temporal lobes. The antibodies were identified in serum and CSF based on the typical staining pattern of AK5 antibodies on a tissue-based assay (here, unfixed mouse brain). Subsequently, they were confirmed by a research laboratory through a cell-based assay. Unlabelled Image • AK5 antibodies are found in patients with non-paraneoplastic limbic encephalitis, mainly in men around 70 years of age. • Patients have extensive limbic lesions and develop severe atrophy, mainly of the medial temporal lobes. • AK5 antibodies can be identified by their staining pattern on a tissue-based assay. Confirmation by a cell-based assay. [ABSTRACT FROM AUTHOR]